These results suggest that, while TP53 mutations are commonly observed, other genetic changes in genes such as CDH1, KMT2D, APC, ATM, MSI‐H, and TMB differ between early‐ and late‐onset cases of GC. This evidence concerns the gene KMT2D and gastric cancer.